2025 Singclean Global Aesthetic Master Symposium Debuted in France

February 10, 2025 02:18 PM AEDT | By Cision
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp

PARIS, Feb. 10, 2025 /PRNewswire/ -- 2025 IMCAS World Congress, the world's largest scientific aesthetics congress, was grandly held in Paris from January 30 to February 1, celebrating its 26th anniversary.

 
SINGCLEAN highlight video in IMCAS 2025

Singclean Medical showcased its flagship HA fillers, Singfiller and Singderm, along with a range of regenerative medical aesthetics innovations at IMCAS. Meanwhile, Singclean successfully held the inaugural Singclean Global Aesthetic Master Symposium with Young Plastic Surgeon Medical Beauty Service Co.,Ltd. and Lazeo, the leading aesthetic medicine center in France. The event brought together global experts to explore the latest advancements in injection techniques and promote the exchange of Eastern and Western aesthetic concepts and further infuse new life into the global aesthetic medicine industry.

Figure 1 Dr.Matt, renowned international plastic surgeon
Figure 1 Dr.Matt, renowned international plastic surgeon

 

Figure 2 Dr.Sercan, German plastic surgeon
Figure 2 Dr.Sercan, German plastic surgeon

The grand opening of the Singclean Global Aesthetic Master Symposium was honored to welcome renowned international plastic surgeon Dr. Matt Stefanelli and German plastic surgeon Dr. Sercan. Dr. Sercan shared his insights on the evolving trends in Western aesthetic medicine, highlighting the increasing demand for multi-site, multi-dose procedures and the increasing number of male patients seeking aesthetic treatments.

Figure 3 Dr. You Xi, the Champion of Singfiller International Injection Competition shared her expertise in using Singfiller to achieve exceptional results in facial contouring.
Figure 3 Dr. You Xi, the Champion of Singfiller International Injection Competition shared her expertise in using Singfiller to achieve exceptional results in facial contouring.

The Symposium was also featured by a presentation by Dr. You Xi, the Champion of Singfiller International Injection Competition, to share her expertise in using Singfiller to achieve exceptional results in both inner and outer facial contouring.

Figure 4 Ms. Luo Laidi, Global Business Director of Singclean, led a team to visit Lazeo
Figure 4 Ms. Luo Laidi, Global Business Director of Singclean, led a team to visit Lazeo

Fostering local academic leadership was a key focus of the Symposium. To gain deeper insights, Ms. Luo Laidi, Global Business Director of Singclean, led a team to visit Lazeo, a leader in the field of aesthetic medicine in Europe, with 170 medical aesthetic clinics in France and Belgium. The visit offered a firsthand look at Lazeo's advanced treatment procedures and meticulous services.

Figure 5 Singderm live injection demonstration
Figure 5 Singderm live injection demonstration

Through a live demonstration, Dr. You Xi showcased the transformative power of Singderm in creating a more defined and youthful facial contour.

Singclean's regenerative medical aesthetic products, including Calcium Hydroxylapatite, Poly-L-lactic Acid, and Polydeoxyribonucleotide also attracted much attention in the Symposium.

In 2025, Singclean Medical will continue the global tour of its Injection Masterclass, keep inviting renowned international aesthetic experts to conduct a series of workshops and training sessions. These events aim to facilitate knowledge exchange and collaboration among medical professionals worldwide, driving the advancement of the global aesthetic medicine industry.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

Two ASX Listed Stocks Giving Bullish Indications

Recent Articles

Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.